Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | MLYCD | O95822 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL103091 | 0.76 | CA12 (0.37) | CA12CA2CA9MLYCD | |
| SCHEMBL29299960 | 0.75 | CYP2D6 (0.36) | — | |
| SCHEMBL9462283 | 0.66 | CA12 (0.48) | CA12CA2CA9MLYCD | |
| SCHEMBL17702635 | 0.66 | MLYCD (0.38) | CA12CA2CA9MLYCD | |
| SCHEMBL23008294 | 0.66 | CA12 (0.30) | CA12CA2 | |
| SCHEMBL2293885 | 0.65 | MLYCD (0.37) | CA12CA2CA9MLYCD | |
| SCHEMBL9250268 | 0.65 | MLYCD (0.37) | CA12CA2CA9MLYCD | |
| SCHEMBL13332903 | 0.63 | CA12 (0.44) | CA12CA2CA9MLYCD | |
| SCHEMBL24370670 | 0.63 | MLYCD (0.36) | CA12CA2CA9MLYCD | |
| SCHEMBL103983 | 0.63 | TSHR (0.36) | MLYCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226113-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | KUMQUAT BIOSCIENCES INC. | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226113-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | TP53, HRAS, KRAS | CA12 2129/4885CA2 3406/4885CA9 3104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.